• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Stock Exchange>Frankfurt Stock Exchange

Frankfurt Stock Exchange

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. MOLOGEN AG: Combination data of TLR9 agonist lefitolimod with checkpoint inhibitors in preclinical tumor models

    MOLOGEN AG: Combination data of TLR9 agonist lefitolimod with checkpoint inhibitors in preclinical tumor models

  2. Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)

    Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)

  3. Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics

    Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics

  4. MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes

    MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes

  5. Haplogen's Novel Antiviral Target Partnered with Evotec Published in 'Nature'

    Haplogen's Novel Antiviral Target Partnered with Evotec Published in 'Nature'

  6. Evotec and Eternygen to Develop Novel Metabolic Disease Therapy

    Evotec and Eternygen to Develop Novel Metabolic Disease Therapy

  7. Evotec to Attend Three Upcoming Investor Conferences

    Evotec to Attend Three Upcoming Investor Conferences

  8. GFT Spotlights 2017 Trends Shaping Financial Services

    GFT Spotlights 2017 Trends Shaping Financial Services

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.